Tino Pereira, CEO of Canada-based Iotron Industries, discussed the electron-beam facility his company opened March 15 in Columbia City, which lies halfway between Fort Wayne and Warsaw in northern Indiana. Iotron already helps some of the orthopedic implant makers in Warsaw alter the strength, flexibility or surface conditions of the materials in the joint replacements they make. That makes its services important in research and development for new products.
European regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
The Indiana Supreme Court said Thursday that the state Family and Social Services Administration can't deny Medicaid, food stamps or welfare to people without first doing a better job of telling them why.
The nation's big insurers are spending millions to carry out President Barack Obama's health care overhaul even though there's a chance the wide-reaching law won't survive Supreme Court scrutiny.
An idea being kicked around the halls of IUPUI would split off the schools of medicine, nursing, dentistry, optometry, health sciences and social work into a separate administrative unit, based in Indianapolis.
Indianapolis-based Eli Lilly and Co. will introduce “over a dozen” new products in China in the next five years, focusing on “unmet needs” such as cancer and diabetes, CEO John Lechleiter said this week.
Decision by industry giant Pfizer Inc. to abandon its generic insulin project is good news for Eli Lilly and Co.
Miscues by WellPoint Inc.’s executives have, over the past year, depressed the health insurer’s stock price nearly 20 percent. That’s the upshot of analyst opinions gathered by Barron’s magazine in a March 15 article.
Sales at OneAmerica Financial Partners Inc. surged 29 percent in 2011, on top of a 24-percent jump in 2010, the Indianapolis-based life insurer announced Monday.
Express Scripts Inc.’s bid to acquire Medco Health Solutions Inc. and create the largest U.S. pharmacy-benefits manager may be delayed by a lawsuit being considered by five states.
Keystone Group, Turkish immigrant Ersal Ozdemir’s 10-year-old development firm, is orchestrating some of central Indiana’s most ambitious projects, including a $15M Broad Ripple parking garage and the $60M million mixed-use Sophia Square in Carmel.
Rates are set to rise as insurers increasingly note the link between older workers’ health and productivity.
Concept is likely ahead of technical ability to make it work.
Physician liaisons are becoming key in recruiting efforts.
Hospitals around Indianapolis and the nation are expanding programs to help people before they become patients. They are trying to teach cooking as well as treat cancer, to do social work as well as do surgery.
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
Even though researchers at the Indianapolis-based Regenstrief Institute Inc. demonstrated more than 20 years ago that electronic health records and test ordering systems significantly reduced costs in Indianapolis’ Wishard Health Services’ system, a recent study of electronic health records among office-based physicians came to the opposite conclusion.
Health care venture capital has become scarcer in Indiana the past two years, but there are indications that angel investors are picking up some of the slack.
Two pharmacy groups opposing Express Scripts Inc.’s proposed acquisition of Medco Health Solutions Inc. said they were asked by the U.S. Federal Trade Commission to suggest ways to revise the $29.1 billion deal so it wouldn’t harm competition.
